Effectiveness of creative story therapy for dementia: A Systematic Review and Meta-Analysis

doi:10.21203/rs.3.rs-3201940/v1

Download PDF

Research Article

Effectiveness of creative story therapy for dementia: A Systematic Review and Meta-Analysis

https://doi.org/10.21203/rs.3.rs-3201940/v1

This work is licensed under a CC BY 4.0 License

Journal Publication

published 14 Sep, 2023

Read the published version in European Journal of Medical Research →

You are reading this latest preprint version

Objective

To conduct a meta-analysis of the effectiveness of creative story therapy versus routine nursing alone for the treatment of dementia.

Methods

We manually searched PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), China VIP Database (VIP), China Biomedical Literature Database (CBM), and Wanfang Data up to May 2023. Randomized controlled trials (RCTs) of creative story therapy combined with routine nursing versus routine nursing for the treatment of dementia were included.

Results

A total of 597 participants were enrolled in the 9 RCTs. Among them, 296 were in the creative story therapy group, and 301 were in the routine nursing group. We found statistically significant effects of creative story therapy combined with routine nursing on cognitive function [standardized mean difference (SMD) = 0.99, 95% CI 0.57, 1.41, P < 0.00001], CSDD score [mean difference (MD) = − 1.71, 95% CI − 3.27, − 0.14, P < 0.00001], quality of life [SMD = 0.97, 95% CI 0.04, 1.90, P = 0.04], and social communication [MD = 0.46, 95% CI 0.17, 0.74, P < 0.00001] between the creative story therapy group and routine nursing groups; no significant difference in change in basic needs communication [MD = 0.09, 95% CI − 0.58, 0.76, P < 0.00001].

Conclusion

This meta-analysis shows that creative story therapy combined with routine nursing has significant effectiveness in improving cognitive function, depression, quality of life, and social communication in people with dementia. More high-quality RCTs are required to validate these results.

Dementia

Alzheimer’s disease

creative story

meta-analysis

clinical trials

Dementia refers to a group of degenerative diseases of the central nervous system, characterized primarily by cognitive impairments.[1] According to the latest data from the World Health Organization (2023), there are approximately 55 million people with dementia (PWD) worldwide.[2] With global population aging and increased life expectancy, it is projected that the number of PWD will reach 130 million by 2050, posing significant challenges to global healthcare systems.[3] Studies on the cost of dementia diseases have shown that the annual cost of dementia care is approximately $30,554, with long-term home care being the major cost driver, and the cost of nursing will increase dramatically, with the deterioration of dementia.[4, 5]

While the use of anti-dementia drugs can partially improve dementia symptoms, their therapeutic effects are limited, only able to control the progression of symptoms, and may come with some adverse reactions, along with the burden of long-term high costs.[6] In comparison, non-pharmacological treatments offer higher safety and acceptability.[7] Non-pharmacological approaches such as music therapy and art therapy have numerous advantages in improving the behavior and psychological symptoms of dementia patients, enhancing cognitive functions, promoting well-being, and reducing caregiver burden.[8–10] Recently, person-centered care (PCC) has gained increasing attention in dementia care.[11, 12] A study indicated that PCC,[13] as a standard for providing long-term services and supports (LTSS) to dementia patients, can be an effective approach in preventing and managing dementia behaviors and psychological symptoms. Creative story therapy is one form of engagement in PCC, simulating genuine person-centered care.[14] TimeSlips, created by Anne Bastings, the director of the University of Wisconsin's Center on Age and Community, is an improvisational storytelling process and a typical form of creative story therapy.[15] In the TimeSlips care process, patients typically sit comfortably in chairs around a facilitator, who guides them in telling stories related to images and other prompts, providing appropriate guidance and adjustments based on each patient's personality and characteristics, encouraging their participation in storytelling and sharing. The facilitator does not correct the content of the patients' stories but creates various conditions for their engagement and repetition of the stories to facilitate communication and sharing among the patients.[16] Various theoretical perspectives support the benefits of creative story therapy, such as cognitive theory, relationship-centered care models, generativity theory, and social-emotional selectivity theory.[17] While these theories differ in content and application, they all emphasize the importance of cognitive factors, which are key to creative story therapy. Creative story therapy can empower dementia patients with memory and functional impairments to express themselves through imagination, thereby preserving their social roles and maintaining their individuality.[18, 19] This intervention process has little restriction on patients' cognitive function, especially memory ability, instead, it can be achieved through their existing capabilities.[20] Recent studies have shown that creative story therapy can help maintain and improve cognitive functions in dementia and mild cognitive impairment patients.[17, 21] A mixed-methods study also found benefits of creative story therapy for dementia patients at various stages.[22] However, the effectiveness of creative story therapy has not been systematically evaluated, and thus, this study aims to meta-analyze its effectiveness.

This meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. The systematic review methodology employed in this study has been registered on the Prospero platform, although it is currently awaiting approval.

Search strategy

A comprehensive scoping search was conducted to gather research published until May 11, 2023. Two independent authors (WBJ and JLM) searched the PubMed, Embase, Cochrane Library, Web of Science, China National Knowledge Infrastructure (CNKI), China VIP Database (VIP), China Biomedical Literature Database (CBM), and Wanfang Database. To ensure the effectiveness of the search, a combination of MeSH terms and relevant keywords was employed. The search terms for this review were ("dementia" or "Alzheimer's disease" or "dementia *" or "Alzheimer's disease *" or "senile dementia") and ("creativity" or "creative expression *" or "creative expression therapy" or "timeslips"). The retrieval strategy was jointly determined by two evaluators and involved a manual search of references in selected studies to identify articles that fulfilled the predetermined criteria.

Qualifications

The inclusion criteria for this review are determined by the "PICOS" principle. The target population consists of individuals aged 60 and above, who were diagnosed with dementia according to the established diagnostic criteria. The intervention focuses on the experimental group receiving creative story therapy, specifically storytelling intervention, while the control group receives routine nursing intervention. The primary outcome of interest centers around overall cognitive function, which can be assessed through standardized scales such as the Mini Mental State Examination (MMSE), the Montreal Cognitive Assessment (MoCA), and the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-cog). Secondary outcomes encompass depression, which can be evaluated using the Kangnai Depression Scale, and quality of life, which can be assessed using validated and standardized quality of life-specific scales for dementia patients, such as the Alzheimer's Disease Quality of Life Scale (QOL-AD). Communication skills can be evaluated through the Functional Assessment of Communication Skills (SFACS). Moreover, the included studies must be randomized controlled trials published in either Chinese or English. On the other hand, the exclusion criteria encompass reviews, qualitative research, conference abstracts, and experimental protocols. Additionally, original research articles without full-text availability or missing key outcome indicator data were excluded. Repeatedly published articles by the same author or team were also excluded. Furthermore, studies with low-quality literature evaluations are not considered in this review.

Research Selection and Data Extraction

The collected research was imported into the EndNoteX9.1 software. Duplicate studies were promptly identified and removed. The title and abstract of each article are then carefully assessed, allowing the reviewers to select studies that meet the predetermined inclusion criteria. To maintain accuracy and consistency, two independent reviewers, WBJ and JLM, screened and extracted the literature. They conduct thorough cross-checking to ensure the reliability of the selected studies. In case of any differences or disagreements, JLM and LYM engaged in thoughtful discussions to reach a consensus. Alternatively, if needed, they seek advice from a third-party expert to resolve any remaining discrepancies. The following characteristics were extracted : author information, publication year, patient age, sample size, details of the intervention measures, duration of the intervention, and assessment scales.

Quality assessment

Two evaluators, WBJ and JLM, independently employed the esteemed Cochrane Risk Bias Assessment Tool[23]. This tool, specifically designed for randomized controlled studies, comprises seven essential questions that comprehensively evaluate various aspects of study quality. These questions encompass critical domains, including random sequence generation, allocation concealment, blinding of implementation, blinding of outcome assessment, completeness of outcome data, selective outcome reporting, and potential biases. Each item is carefully classified as either low risk, unclear, or high risk, indicating the level of potential bias associated with the study. To ensure accuracy and consistency, any discrepancies or differences in evaluation are meticulously addressed. In such cases, the Third Reviewer, LYM, serves as an impartial mediator, providing invaluable expertise to resolve any remaining disagreements and guide the final assessment.

Statistical analysis

We used two software tools, RevMan 5.4 and Stata software (version 14), to perform comprehensive statistical analysis. All the outcome indicators examined in this meta-analysis consist of continuous variables. Depending on the consistency of the evaluation tools employed across studies, we will utilize different effect indicators. Specifically, when the evaluation tools are consistent, we will employ the mean difference (MD) as the effect indicator. Conversely, when variations in evaluation tools are inconsistent, we will employ the standardized mean difference (SMD) as the effect indicator. To determine the magnitude of the effect size, we will utilize Cohen's criterion. According to Cohen's criterion, effect sizes between SMD (or MD) ≥ 0.20 and < 0.50 are considered small, SMD (or MD) ≥ 0.50 and < 0.8 are considered moderate, and SMD (or MD) ≥ 0.8 are considered large, thereby offering a comprehensive understanding of the impact.

Heterogeneity among the included studies was assessed through the I² statistic and chi-square test statistics, and a random effects model was used when heterogeneity was more than 50%. Otherwise, a fixed effects model will be applied to combine the data. subgroup analysis was conducted to further investigate the potential sources of heterogeneity and sensitivity analysis was conducted to assess the impact of individual studies on the overall findings and the stability of the results. Additionally, to evaluate the potential publication bias, funnel plots will be utilized, providing a visual representation of the distribution of studies and their corresponding effect sizes. Furthermore, to detect and quantify any publication bias present, we will employ both funnel plots and Egg's test, a widely recognized method for assessing publication bias.[24]

Literature search

Figure 1 shows the search strategy. In our literature search, a total of 731 articles relevant to our study were discovered. We removed 244 duplicate articles, leaving us with 487 unique and relevant articles to delve into. After a thorough evaluation of these articles against our eligibility criteria, we found that 9 studies were proved to be fitting for our meta-analysis. [25–33]

Study Characteristics

Table 1 presented the basic characteristics of the nine included studies which were conducted ranging from 2010 to 2021, with an enrollment of 597 participants. Within this cohort, 296 participants were in the creative story therapy group, and 301 participants constituted the routine care group. The sample sizes within the studies varied from 20 cases to 112 cases. All studies reported the mean and SD of age for participants. The duration that the studies lasted ranged from 4 to 8 weeks. The studies reported different outcomes of interest, with seven studies exploring changes in cognitive function, five studies focusing on the Cornell Scale for Depression in Dementia (CSDD), four studies delving into quality of life, and two studies investigating the changes in communication skills before and after the patient intervention.

Table 1

Characteristics of the included studies.
First author, (publication year)	Country	Diagnosis	Experimental Group N, age (mean ± SD) on baseline	Routine care Group N, age (mean ± SD) on baseline	Control Intervention and duration/intensity	Outcomes Measured:	Interventionist
Phillips, 2010	America	11 ≤ MMSE＜24	N = 28, Age = 83.42 ± 8.0	N = 28, Age = 85.75 ± 6.2	Type of participation: Group ranging from 6–12 person Frequency: 2 weekly Duration: 1 hour Length: 6 weeks	CSDD communication skills QOL-AD	first author study nurse facilitators
Wang, 2013	China	10＜MMSE	N = 29, Age = 83.0 ± 6.9	N = 29, Age = 82.4 ± 6.84	Type of participation: 1- to-1 intervention alone Frequency: 1 weekly Duration: 45-min Length: 8 weeks	Cognitive functioning CSDD DQOL	Nurse
Lin, 2019	China	11 ≤ MMSE＜17	N = 43, Age = 85.3 ± 5.89	N = 48, Age = 84.6 ± 8.11	Type of participation: Group ranging from 6–7 person Frequency: 2 weekly Duration: 1hour Length: 6 weeks	Cognitive functioning CSDD communication skills, QOL-AD	Psychotherapists Facilitators, video recorder
Ye, 2019	China Taiwan	Mild and moderate dementia	N = 10, Age = 83.70 ± 3.8	N = 10, Age = 88.0 ± 4.42	Type of participation: Group Frequency: 1 weekly Duration: 1 hour Length: 6 weeks	CSDD QOL	Nurses,Social workers, care and service staff
Cai, 2019	China	Mild and moderate dementia	N = 20, Age = 68.45 ± 3.73	N = 20, Age = 69.85 ± 4.11	Type of participation: Group ranging from 6-10person Frequency: 1 weekly Duration: 40-60-min Length: 7 weeks	Cognitive functioning CSDD	Nurse therapeutist
Wang, 2020	China	Alzheimer disease	N = 38, Age ≥ 60	N = 38, Age ≥ 60	Type of participation: Group ranging from 6–7 person Frequency: 1 weekly Length: 4 weeks	Cognitive functioning	Nurses
Xia, 2020	China	Alzheimer disease	N = 32, Age ≥ 60	N = 32, Age ≥ 60	Type of participation: Group ranging from 6–7 person Frequency: 1 weekly Length: 4 weeks	Cognitive functioning	Nurses
Shen, 2021	China	Mild dementia	N = 40, Age = 73.12 ± 7.3	N = 40, Age = 73.1 ± 7.49	Type of participation: Group ranging from 6-8person Frequency: 2 weekly Duration: 1 hour Length: 6 weeks	Cognitive functioning	Nurse Graduate students doctor
Fan, 2021)	China	Alzheimer disease	N = 56, Age = 69.83 ± 5.62	N = 56, Age = 69.44 ± 5.39	Type of participation: Group ranging from 6-10person Frequency: 1 weekly Duration: 40-60-min Length: 6 weeks	Cognitive functioning	Nurse( host, recorder, site staff)

Methodology Quality

In terms of random sequence generation, 6 studies were determined to be at low risk of bias while 3 studies were judged to be unclear. In regard to allocation concealment, only 2 studies were judged to have a low risk of bias, and the other trials were judged to have an unclear risk of bias. Blinding study subjects proved challenging due to ethical considerations. For blinding of personnel, only 2 studies provided detailed information regarding their blinding methods during intervention implementation, 5 studies were judged to be at an unclear risk and 2 studies were judged to be high risk primarily due to insufficient disclosure of specific intervention details. 3 study were considered as high risk on the outcome measures. All studies reported baseline comparability without selective reporting and other high risks of bias. For a comprehensive overview of the assessed risk of bias, please refer to supplemental Table S1.

Meta-analysis Results

Cognitive function

An ensemble of 7 studies reported the scores for cognitive function.[25–27, 29–32] Within the 7 studies, a total of 521 subjects were divided into the creative story therapy group (258 subjects) and a routine care group (263 subjects). The meta-analysis results demonstrated that the creative story therapy group had significantly higher scores than the routine care group (SMD = 0.99, 95% CI 0.57, 1.41, P < 0.00001, I² = 80%) (Fig. 3). Then, we conducted a subgroup analysis according to the intervention period (subgroups: intervention period ≤ 6 weeks and intervention period > 6 weeks). The heterogeneity within the two subgroups was I² = 85% and 32% respectively (Fig. 4), while the intersubgroup heterogeneity was not very evident (I² = 0%). The dementia type can be divided into subgroup AD and subgroup PWD (Fig. 5), and the heterogeneity within the two subgroups was I² = 42% and 58% respectively, and the inter-subgroup heterogeneity was too evident (I² = 87.8%). The estimated MDs were 1.33 and 0.99. We then performed a sensitivity analysis by changing the effect model and eliminating the literature one-by-one method, which showed that deleting any literature had little effect on the combined SMD values, that is, the results of the pooled result were reliable (refer to Supplemental Table S2).

Figure 7 shows a funnel plot of the cognitive function, and no obvious publication bias was observed according to the funnel plot and Eggers' test (p = 0.872, refer to Supplemental Table S3).

CSDD

Five studies reported the scores for cognitive function.[25, 27, 28, 30, 33] A total of 265 subjects, with 130 subjects in the creative story therapy group and 135 subjects in the routine care group, were included in these studies. The meta-analysis results revealed that the creative story therapy group had significantly lower scores than the routine care group (MD = − 1.71, 95% CI − 3.27, − 0.14, P < 0.00001, I² = 78%, Fig. 7). Then, we conducted a subgroup analysis, and the intervention period was divided into subgroups ≤ 6 weeks and subgroups > 6 weeks (Fig. 8), and the heterogeneity within the two subgroups was respectively not too evident (I² = 16% and 0%), but the inter-subgroup heterogeneity was evident (I² = 92.4%). The estimated MDs were − 0.56 and − 3.35. We then performed a sensitivity analysis by changing the effect model and eliminating the literature one-by-one method. Both subtotal and overall effect sizes were still steady with reduced heterogeneity after the two studies^[27,28] ( refer to Supplemental Table S2) were removed.

Figure 9 shows a funnel plot of the CSDD, and no obvious publication bias was observed according to Eggers' test(p = 0.304, refer to Supplemental Table S4).

Quality of life

Four studies examined the impact of the intervention on quality of life.[27, 28, 30, 32] In total, these studies included 269 subjects, with 132 subjects in the creative story therapy group and 137 subjects in the routine care group. The meta-analysis findings demonstrated that the creative story therapy group had significantly higher quality of life scores than the routine care group (SMD = 0.97, 95% CI 0.04, 1.90, p = 0.04, I² = 92%, refer to Fig. 10). Given the high heterogeneity, a subgroup analysis was conducted based on the intervention frequency. The subgroups were categorized as "once in 1 week" and "twice a week" (refer to Fig. 11). The pooled results indicated a favorable outcome for the "Once in 1 week" subgroup, with reduced heterogeneity (MD = 1.80, 95% CI 1.15, 2.45, I² = 57%, p < 0.00001, 2 studies).

The sensitivity analysis revealed that the combined effect size was influenced by the removal of any literature source except for Phillips et al (refer to Supplemental Table S2).[28] Consequently, the pooled results should be interpreted with caution due to their instability.

Social communication

Two studies examined the impact of the creative story therapy on social communication.[27, 28] These studies included a total of 147 subjects, with 71 subjects in the creative story therapy group and 76 subjects in the routine care group. The pooled results of the meta-analysis revealed that the creative story therapy group had significantly higher scores in social communication than the routine care group (MD = 0.46, 95% CI 0.17, 0.74, p < 0.00001, I² = 0%, refer to Fig. 12).

Basic needs communication

Two studies examined the impact of the creative story therapy on basic needs communication.[27, 28] These studies included a total of 147 subjects, with 71 subjects in the creative story therapy group and 76 subjects in the routine care group. There was no significant difference between the creative story therapy group and routine care group in basic needs communication (MD = 0.09, 95% CI − 0.58, 0.76, p < 0.00001, I² = 78%, refer to Fig. 13)

This systematic review meta-analyzed the effects of creative story therapy combined with routine nursing on cognitive function, depression, quality of life, and communication in dementia patients. A total of 597 subjects participated in nine randomized controlled trials. The quality of the included studies was considered moderate overall. The research findings suggest that creative story therapy yields significant benefits in terms of cognitive function, reduction of depression, improvement of quality of life, and social communication compared to routine care in dementia patients. However, no significant difference was found in basic needs communication.

Creative story therapy combined with routine nursing appears to have a great potential in improving cognitive function of dementia patients. Among the seven studies evaluating cognitive function, six studies [25, 26, 29–32] reported positive effects, with effect sizes ranging from moderate to large (SMD ranged from 0.44 to 1.74) based on previous research.[34] Creative story therapy, as a collective narrative project, stimulates the imagination of dementia patients, empowering them as active contributors rather than passive recipients during social activities. Through storytelling, patients can express themselves and the repeated review of activities aids in stimulating the cerebral cortex,[35] thus improving memory function.[36] Additionally, a study by Luo et al conducted a single-blind RCT on 73 people with mild cognitive impairment, demonstrating enhanced strength and range of brain functional network connectivity in elderly individuals with MCI following a 12-week creative art expression intervention involving painting and storytelling. Moreover, this meta-analysis suggests that an intervention duration of 4–8 weeks can lead to improved cognitive function. Notably, creative story therapy exhibits superior efficacy in improving cognitive function in Alzheimer's disease patients, and sensitivity analysis suggests that the combined results are reliable.

Creative story therapy combined with routine nursing may prevent depression in dementia patients.[37] Depression is an important factor that worsens the condition of dementia patients and reduces their quality of life .[38] Studies have shown that up to 50% of AD patients develop depressive symptoms or are diagnosed with depression during the course of their illness.[39] Creative story therapy is a social activity that is effective in reducing depression by increasing social activity in people with dementia.[37] In this process, dementia patients could actively express their outlook on life and values, and mutual communication can help alleviate negative emotions in patients and reduce depression. A systematic review showed that reminiscence therapy reminiscence, which takes a life story approach as the core intervention, can effectively improve the depressive state of AD patients, and they further noted that 30/35-min at least once a week over a period of 12 weeks is the optimal intervention duration.[40] Consistent with previous findings, our results suggested than an intervention duration of creative story therapy of more than 6 weeks has a better effect in reducing depression in patients.

Creative story therapy combined with routine nursing has the potential to enhance the quality of life of dementia patients, although conclusions are cautious. Among the four studies that reported on quality of life, two studies^[30,32] demonstrated significant positive effects (SMD ranged from 1.48 to 2.14) in improving the quality of life of dementia patients. Fay et al provided creative story therapy to eight dementia patients over a period of 32 consecutive weeks during the COVID-19 pandemic, yielding a positive impact on crucial areas of quality of life, such as emotion, energy level, and cognitive function.[21] Furthermore, George et al conducted a timeslips intervention involving 15 medical students, revealing that creative story therapy contributed to changing the students' attitudes toward dementia patients, improving their communication skills, and enhancing their interactions with patients.[41] This improvement in the quality of care ultimately promotes a better quality of life for patients. However, Houser et al., 2014 conducted a six-week timeslips intervention with ten dementia patients and found no significant changes in emotional and behavioral symptoms.[35] Therefore, additional studies are warranted to further confirm the impact of creative story therapy on quality of life.

Creative story therapy combined with routine nursing may help improve social communication in dementia patients, although no significant difference was found in basic needs communication. Within this meta-analysis, only one of the two studies reporting on social communication in dementia patients demonstrated a positive effect, albeit with a small effect size (MD ranged from 0.44 to 0.52).[27] Furthermore, two studies reported on basic needs communication in dementia patients, revealing no statistical difference in improvement between creative story therapy and routine care. This outcome could be attributed to the limited number and sample size of the included studies. Consequently, future research should prioritize conducting high-quality studies with larger sample sizes to confirm the impact of creative story therapy on social communication and basic needs communication.

This meta-analysis provides valuable insights into the effectiveness of creative story therapy, facilitating the further application of this therapeutic approach in dementia patients and emphasizing the importance of person-centered care philosophy in dementia management. However, our research has certain limitations. First, we solely searched for literature published in Chinese and English, excluding literature published in other languages. Second, the relatively small sample sizes in the included studies (with a minimum of 20 participants) are associated with the group intervention nature of creative story therapy. Thus, future research should prioritize conducting multicenter studies with larger sample sizes. The overall quality of the literature included in this review is also a factor influencing our conclusions. Limited descriptions of intervention implementation and blind evaluation methods in the included studies necessitate future high-quality research efforts, with a focus on implementing blinding measures to minimize bias.

This comprehensive meta-analysis supported the efficacy of creative story therapy combined with routine nursing in enhancing cognitive function and alleviating depression in individuals living with dementia. The findings from individual studies suggest promising outcomes in terms of improving quality of life and fostering social communication, although statistical significance was not observed in basic needs communication. To corroborate and reinforce these findings, it is imperative that future research endeavors prioritize conducting high-quality studies with larger sample sizes.

PWD, people with dementia; PCC, person-centered care; PRISMA, Preferred Reporting Items for Systematic Reviews and Meta-Analyse; RCTs, randomized controlled trials; MD, mean difference; CSDD, Cornell Scale for Depression in Dementia

Ethics approval and consent to participate

Not applicable

Availability of Data and Materials

The datasets used or analyzed during the current study are available from the corresponding author on reasonable request.

Competing Interest

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Funding

This work was supported by the National Natural Science Foundation of China (No. 61263033), the Research program of Medical and Health Science and Technology Development Plan Project of Shandong Province (No. 202103070653), the Natural Science Foundation of Shandong Province (No. ZR2022MH124), and the Natural Science Foundation of Shandong Province (No. ZR2021MH349), the Youth Science Foundation of Shandong First Medical University (No. 202201-105), the Shandong Medical and Health Technology Development Fund (No. 202103070325), the Shandong Province Traditional Chinese Medicine Science and Technology Project (No. M-2022216) and the Nursery Project of the Affiliated Tai’an City Central Hospital of Qingdao University (No. 2022MPM06).

.Author Contributions

Wei Baojian and Li Dawei conceived the study. Ma Jinlong and Gao Shuang collected the data and drafted the manuscript. Lang Yanmei revised the manuscript and language. Wan Xueying conducted the subgroup analysis. All authors have read and approved the manuscript.

Acknowledgement

The authors thank XX for editing this manuscript.

Authors' information

Not applicable

Shinan-Altman S, Werner P. Illness representations of dementia: A scoping review. Clin Interv Aging. 2019;14:179-93.
Dementia: World Health Organization; 2023 [updated March 15th]. Available from: https://www.who.int/news-room/fact-sheets/detail/dementia.
Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D, et al. Dementia prevention, intervention, and care. The lancet. 2017;390(10113):2673-734.
Schaller S, Mauskopf J, Kriza C, Wahlster P, Kolominsky-Rabas PL. The main cost drivers in dementia: a systematic review. Int J Geriatr Psychiatry. 2015;30(2):111-29.
Jönsson L, Tate A, Frisell O, Wimo A. The costs of dementia in Europe: an updated review and meta-analysis. Pharmacoeconomics. 2023;41(1):59-75.
Tao P, Xu W, Gu S, Shi H, Wang Q, Xu Y. Traditional Chinese medicine promotes the control and treatment of dementia. Front Pharmacol. 2022;13:1015966.
Robinson L, Hutchings D, Dickinson H, Corner L, Beyer F, Finch T, et al. Effectiveness and acceptability of non‐pharmacological interventions to reduce wandering in dementia: A systematic review. Int J Geriatr Psychiatry. 2007;22(1):9-22.
Letrondo PA, Ashley SA, Flinn A, Burton A, Kador T, Mukadam N. Systematic review of arts and culture-based interventions for people living with dementia and their caregivers. Ageing Res Rev. 2022;83:101793.
Quail Z, Carter MM, Wei A, Li X. Management of cognitive decline in Alzheimer's disease using a non-pharmacological intervention program: A case report. Medicine. 2020;99(21):e20128.
Zhang Y, Cai J, An L, Hui F, Ren T, Ma H, et al. Does music therapy enhance behavioral and cognitive function in elderly dementia patients? A systematic review and meta-analysis. Ageing Res Rev. 2017;35:1-11.
Kim SK, Park M. Effectiveness of person-centered care on people with dementia: a systematic review and meta-analysis. Clin Interv Aging. 2017:381-97.
Lee KH, Lee JY, Kim B. Person-centered care in persons living with dementia: A systematic review and meta-analysis. Gerontologist. 2022;62(4):e253-e64.
Wagner LM, Van Haitsma K, Kolanowski A, Spetz J. Recommendations to deliver person-centered long-term care for persons living with dementia. J Am Med Dir Assoc. 2021;22(7):1366-70.
Kim S. A story of a healing relationship: The person-centered approach in expressive arts therapy. J Creat Ment Health. 2010;5(1):93-8.
Basting AD. Reading the story behind the story: Context and content in stories by people with dementia. Generations. 2003;27(3):25-9.
Swinnen A, de Medeiros K. Participatory arts programs in residential dementia care: Playing with language differences. Dementia. 2018;17(6):763-74.
Kim S, Chee KH, Gerhart O. Generativity in creative storytelling: Evidence from a dementia care community. Innov Aging. 2020;4(2):igaa002.
Swinnen A, Medeiros KD. “Play” and people living with dementia: A humanities-based inquiry of TimeSlips and the Alzheimer’s Poetry Project. Gerontologist. 2018;58(2):261-9.
Chen S-Q, Wang Z-S, Ma Y-X, Zhang W, Lu J-L, Liang Y-R, et al. Neuroprotective effects and mechanisms of tea bioactive components in neurodegenerative diseases. Molecules. 2018;23(3):512.
Basting AD. TimeSlips: Creativity for People with Dementia. Age in Action. 2013;28(4):1-6.
Fay SM, García-Toro M, Hincapié Henao L, Andrade Villegas Á, Lopera F. Creativity during COVID-19: Evaluating an online TimeSlips storytelling program for people living with dementia during quarantine in Colombia. Gerontologist. 2023. doi: 10.1093/geront/gnac191.
Vigliotti AA, Chinchilli VM, George DR. Evaluating the Benefits of the TimeSlips Creative Storytelling Program for Persons With Varying Degrees of Dementia Severity. Am J Alzheimers Dis Other Demen. 2019;34(3):163-70.
Cochrane. RoB 2: A revised Cochrane risk-of-bias tool for randomized trials: Cochrane; Available from: https://methods.cochrane.org/bias/resources/rob-2-revised-cochrane-risk-bias-tool-randomized-trials.
Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315(7109):629-34.
Cai Z, Gao J, Li F. Effect of creative story therapy in elderly patients with moderate dementia. Chin J Mod Nurs. 2019;25(13):1595-9.
Fan Y, Gu Y. Effect of creative story therapy on senile dementia patients. Chin J Soc Med. 2021;38(5):587-90.
Lin R, Chen H-Y, Li H, Li J. Effects of creative expression therapy on Chinese elderly patients with dementia: an exploratory randomized controlled trial. Neuropsychiatr Dis Treat 2019:15:2171-80.
Phillips LJ, Reid-Arndt SA, Pak Y. Effects of a creative expression intervention on emotions, communication, and quality of life in persons with dementia. Nurs Res. 2010;59(6):417.
Shen Y, Chen H, Liu M, Shao L, Shen C, Wang F, et al. Effect of Creative Story Therapy on Alexithymia in Patients with Mild Dementia. J Nurs. 2021;28(11):70-3.
Wang L, Shen C. Intervention practice in older age dementia based on life story books. Chin J Gerontol. 2013;33(21):5239-41.
Wang L. The impact of creative story therapy on cognitive function in patients with Alzheimer's disease. Electronic journal of practical gynecological endocrinology. Electr J Pract Gynecol Endocrinol. 2020;7(36):96-7.
Xia Y. The impact of creative story therapy on cognitive function and quality of life in patients with Alzheimer's disease. Chin Sci Technol J Med Health. 2020(11):414-6.
Yeh Y-T, Lin Y-F, Liu MF. Effects of TimeSlips on Depressive Symptoms and Quality of Life in People With Dementia in Day Care Centers. J Nurs. 2019;66(6):65-72.
Dorris JL, Neely S, Terhorst L, VonVille HM, Rodakowski J. Effects of music participation for mild cognitive impairment and dementia: A systematic review and meta-analysis. J Am Geriatr Soc. 2021;69(9):2659-67.
Houser WS, George DR, Chinchilli VM. Impact of TimeSlips creative expression program on behavioral symptoms and psychotropic medication use in persons with dementia in long-term care: a cluster-randomized pilot study. Am J Geriatr Psychiatry. 2014;22(4):337-40.
Ismail S, Dodd E, Christopher G, Wildschut T, Sedikides C, Cheston R. The Content of Nostalgic Memories Among People Living with Dementia. Int J Aging Hum Dev. 2022;94(4):436-58.
Dunphy K. The effectiveness of expressive arts therapies: A review of the literature. Psychother Couns J Aust. 2014;2(1):1-16.
Tomasović S, Sremec J, Košćak Lukač J, Sedlić M, Klepac N. The Prevalence of Depression in Dementia Syndrome. Psychiatr Danub. 2022;34(4):700-5.
Orgeta V, Tabet N, Nilforooshan R, Howard R. Efficacy of antidepressants for depression in Alzheimer’s disease: systematic review and meta-analysis. J Alzheimers Dis. 2017;58(3):725-33.
Cammisuli DM, Cipriani G, Giusti EM, Castelnuovo G. Effects of Reminiscence Therapy on Cognition, Depression and Quality of Life in Elderly People with Alzheimer’s Disease: A Systematic Review of Randomized Controlled Trials. J Clin Med. 2022;11(19):5752.
George DR, Stuckey HL, Dillon CF, Whitehead MM. Impact of participation in TimeSlips, a creative group-based storytelling program, on medical student attitudes toward persons with dementia: A qualitative study. Gerontologist. 2011;51(5):699-703.

No competing interests reported.

Download PDF

Journal Publication

published 14 Sep, 2023

Read the published version in European Journal of Medical Research →

Editorial decision: Major revision
09 Aug, 2023
Reviews received at journal
07 Aug, 2023
Reviewers agreed at journal
01 Aug, 2023
Reviewers agreed at journal
30 Jul, 2023
Reviewers invited by journal
30 Jul, 2023
Editor assigned by journal
27 Jul, 2023
Submission checks completed at journal
27 Jul, 2023
First submitted to journal
25 Jul, 2023

You are reading this latest preprint version

Effectiveness of creative story therapy for dementia: A Systematic Review and Meta-Analysis

Status:

Journal Publication

Version 1

Abstract

Figures

Introduction

Methods

Statistical analysis

Result

Meta-analysis Results

CSDD

Discussion

Conclusion

Abbreviations

Declarations

References

Additional Declarations

Supplementary Files

Status:

Journal Publication

Version 1